Macrogenics shares rise 7.47% intraday after CEO to present at H.C. Wainwright 27th Annual Global Investment Conference.

Wednesday, Sep 3, 2025 1:02 pm ET1min read
Macrogenics, Inc. rose 7.47% in intraday trading, with the company announcing that its President & Chief Executive Officer, Eric Risser, will present at the H.C. Wainwright 27th Annual Global Investment Conference on September 8, 2025. The presentation is expected to provide insights into the company's innovative antibody-based therapeutics for cancer treatment, which may have contributed to the positive market sentiment.

Macrogenics shares rise 7.47% intraday after CEO to present at H.C. Wainwright 27th Annual Global Investment Conference.

Comments



Add a public comment...
No comments

No comments yet